期刊文献+

氯沙坦与依那普利对高血压患者颈动脉内膜中层厚度的影响 被引量:1

下载PDF
导出
摘要 [目的]探讨氯沙坦与依那普利在降低颈动脉内膜中层厚度中的作用.[方法]本院门诊治疗的原发性高血压患者126例,随机分为两组,A组患者服用氯沙坦治疗;B组患者服用依那普利治疗,对两组患者治疗前后的高血压及颈动脉内膜中层厚度(IMT)进行测定并进行统计学分析.[结果]两组患者药物治疗后,血压均获得较好的控制,治疗后4、8、16周血压均逐步下降,其中4、8、16周血压下降与治疗前血压对比有统计学意义(P〈0.05).两组患者用药后IMT逐渐降低,其中治疗后8、16周两组治疗组IMT均较治疗前为低,并对比结果有统计学差别(P〈0.05).而在治疗后16周中A组IMT为(0.663±0.178mm),显著低于B组的(0.716±0.189)mm,两组对比有统计学差异(P〈0.05).[结论]氯沙坦及依那普利在降低患者高血压方面均疗效显著,且在本次实验中,氯沙坦降低颈动脉内膜中层厚度作用优于依那普利.
出处 《医学临床研究》 CAS 2011年第3期544-545,共2页 Journal of Clinical Research
  • 相关文献

参考文献6

  • 1Grobbee DE,Bots ML.carotid artery intmia-media thickness as an indicator of generalized atherosclerosis[J].J Intern Med,1994,236(5):567-573.
  • 2TuLing,Weiwei,liu Xiaoqing,et al.Endothelial function and carotid artery wall thickening in patients with early essential hypertension[J].J Tongji Medical University,1999,19:288.
  • 3Lorenzo G,Stefano T,Agostino V,et al.Endothelial function and common carotid artery wall thickening in patients with essential hypertension[J].Hypertension,1998,32:25.
  • 4李雅男,林培林.氯沙坦与雷米普利对高血压患者颈动脉内膜中层厚度的影响[J].实用心脑肺血管病杂志,2007,15(12):905-908. 被引量:2
  • 5Ikeda H,Minamikawa J,Nakamura Y.Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study:amlodipine vs.ARB in atherosclerosis study)[J].Diabetes Res Clin Pract,2009,83(1):50-53.
  • 6Sonoda M,Aoyagi T,Takenaka K.A one-year study of the antiatherosclerotic effect of the angiotensin Ⅱ receptor blocker losartan in hypertensive patients.A comparison with angiotension-converting enzyme inhibitors[J].Int Heart J,2008,49(1):95-103.

二级参考文献9

共引文献1

同被引文献13

  • 1沙坦类药物的降压外作用[J].中华高血压杂志,2007,15(3):177-179. 被引量:13
  • 2Riccioni G. The effect of antihypertensive drugs on carotid intima media thickness: an up-to-date review [J]. Current Medicinal ChemistryCurr Med Chem, 2009,16(8):988-996.
  • 3Sonoda M, Aoyagi T, Takenaka K, et al. A one-year study of the antiatherosclerotic effect of the angiotensin-ll receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors [J]. Int Heart J, 2008,49(1):95-103.
  • 4Baguet JP, Asmar R, Valensi P, et al. Effects of candesartan cilexetiI on carotid remodeling in hypertensive diabetic patients: the MITEC study [J]. Vasc Health Risk Manag, 2009,5(1): 175-183.
  • 5Yamamoto K, Ozaki H, Takayasu K, et al. The effect of losartan and amlodipine on left ventricular diastotic function and atheroselerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study [J]. Hypertens Res, 2011,34(3):325-330.
  • 6Kinouchi K, Ichihara A, Sakoda M, et al. Effects of telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients [J]. Kidney Blood Press Res, 2010,33(4):304-312.
  • 7lasegawa H, Takano H, Narumi H, et al. Effects of telmisar- tan and losartan on cardiovascular protection in Japanese hyp- ertensive patients[J].Hypertens Res, 2011,34(11): 1179-1184.
  • 8Lethen H,Tries HP, Kersting S, et al. Improvement of coronary mierovascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension [J]. J Clin Hypertens (Greenwich),2011,13(3): 155-161.
  • 9Mortsell D, Malmqvist K, Held, C, et al. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventrieular Hypertrophy Investigation versus Atenolol (SILVHIA) study [J]. J Intern Med,2007,261(5):472-479.
  • 10~edeseo MA, Natale F, Calabro R. Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients [J]. J Clin Hypertens (Greenwich), 2006,8(9):634-641.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部